Hair Drug Testing Market Report 2026

The hair drug testing market size has grown rapidly in recent years. It will grow from $2.07 billion in 2025 to $2.29 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to expansion of workplace drug testing policies, rising law enforcement screening requirements, increased awareness of substance abuse issues, adoption of laboratory-based testing methods, availability of standardized testing kits.

The hair drug testing market size is expected to see rapid growth in the next few years. It will grow to $3.4 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing investments in automated drug testing technologies, rising demand for high-throughput testing solutions, expansion of regulated workplace screening, growing focus on accuracy and traceability, increasing use of advanced mass spectrometry techniques. Major trends in the forecast period include increasing adoption of advanced analytical testing methods, rising demand for long-term drug detection solutions, growing use of automated laboratory analyzers, expansion of workplace and legal drug screening programs, enhanced focus on tamper-resistant testing.

The growing concern over substance abuse is expected to drive the growth of the hair drug testing market in the coming years. Substance abuse refers to the harmful or hazardous consumption of psychoactive substances, including alcohol and drugs, which can result in physical, mental, or social impairment. Heightened concern around substance abuse is largely linked to rising stress levels and mental health challenges, as individuals may turn to drugs or alcohol as coping mechanisms for anxiety, depression, or intense life pressures. Hair drug testing supports substance abuse management by offering a reliable, long-term detection method that enables early intervention, tracks recovery progress, and helps prevent relapse. For example, in April 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 48.5 million people aged 12 and older in the United States - representing 17.1% of the population - experienced a substance use disorder in 2023. Consequently, increasing concern about substance abuse is propelling the growth of the hair drug testing market.

Companies operating in the hair drug testing market are focusing on innovative solutions, such as advanced reporting analytics, to improve accuracy, simplify result interpretation, and support informed decision-making. Advanced reporting analytics involve the use of sophisticated software and data analysis tools to organize, interpret, and visualize testing results, delivering faster, more precise, and actionable insights than traditional reporting methods. For instance, in March 2025, Psychemedics Corporation, a US-based public medical laboratory and research company specializing in hair drug testing, introduced its Quartile Reporting feature. This innovation allows organizations to benchmark individual results against a 12-month dataset of positive tests segmented into four quartiles - lower, median, upper, and highest - providing clearer context for decision-making. By offering real-time analytics and detailed trend data, this feature helps organizations make more informed hiring, retention, and compliance decisions.

In April 2023, Phenna Group Holdings Limited, a UK-based testing, inspection, certification, and compliance (TICC) company, acquired Cansford Laboratories Ltd for an undisclosed amount. Through this acquisition, Phenna Group sought to strengthen its expanding health sciences platform by adding complementary capabilities to its existing portfolio. Cansford Laboratories Ltd is a UK-based provider of hair drug testing services.

Major companies operating in the hair drug testing market are Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific, National Medical Services Inc., USA Mobile Drug Testing, DriverCheck Inc., MVZ Labor Dr. Limbach And Kollegen, Randox Testing Services, Phamatech Inc., The Drug Detection Agency, Accredited Drug Testing Inc., Crystal Health Group, AlphaBiolabs Ltd., Toxlogic Pty Ltd., American Screening Corporation Inc., Australian Workplace Drug Testing Services, DNA Forensics Laboratory Pvt. Ltd., US Health Testing, AMH Nationwide, Brassets Group.

North America was the largest region in the hair drug testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hair drug testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hair drug testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the hair drug testing market by increasing costs of imported laboratory analyzers, chromatography systems, reagents, and consumables used in forensic and clinical testing. Laboratories in North America and Europe are most affected due to reliance on imported analytical instruments, while Asia-Pacific faces higher export-related cost pressures. These tariffs are raising testing service costs and extending equipment replacement cycles. However, they are also encouraging domestic manufacturing of testing kits, regional reagent production, and investment in local laboratory infrastructure.

The hair drug testing market research report is one of a series of new reports that provides hair drug testing market statistics, including hair drug testing industry global market size, regional shares, competitors with a hair drug testing market share, detailed hair drug testing market segments, market trends and opportunities, and any further data you may need to thrive in the hair drug testing industry. This hair drug testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hair drug testing is a screening method used to identify the presence of drugs or their metabolites in a person’s hair. It offers a long-term detection window, generally reflecting drug use over a period of up to 90 days. The process involves analyzing a small hair sample, typically collected from the scalp or other body areas. This method is widely adopted in workplaces, legal proceedings, and rehabilitation programs due to its accuracy and strong resistance to tampering.

The main product types of hair drug testing include kits, analyzers, and consumables. Kits are specialized diagnostic tools developed to detect drugs or their metabolites in hair samples, enabling reliable identification of past substance use over an extended timeframe. Hair drug testing is used to detect substances such as cocaine, marijuana, opiates, amphetamines, and others. These products are applied across various settings, including workplace drug testing, law enforcement, drug treatment programs, and others, and are utilized by end users such as employers, criminal justice systems, drug treatment centers, hospitals, and other organizations.

The hair drug testing market consists of revenues earned by entities by providing services such as laboratory testing services, on-site collection services, screening and verification services, and forensic and legal testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The hair drug testing market also includes sales of instant hair drug test strips, hair collection devices, and hair drug test panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.